Genexine Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.7%.

Top 17 shareholders own 24.82% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.3%	HANDOK Inc.	6,048,534	₩35.6b	0%	no data
5.75%	Young-Chul Sung	2,617,116	₩15.4b	7.47%	no data
2.54%	The Vanguard Group, Inc.	1,154,998	₩6.8b	-0.39%	no data
1.13%	Samsung Asset Management Company, Ltd.	512,824	₩3.0b	0%	0.01%
0.78%	Dimensional Fund Advisors LP	353,394	₩2.1b	0%	no data
0.34%	Yoo-Seok Seo	156,124	₩918.0m	21.8%	no data
0.33%	Mirae Asset Global Investments Co., Ltd.	149,420	₩878.6m	-42.5%	no data
0.18%	Norges Bank Investment Management	82,233	₩483.5m	0%	no data
0.18%	KB Asset Management Co., Ltd.	80,953	₩476.0m	0%	no data
0.12%	Charles Schwab Investment Management, Inc.	56,256	₩330.8m	0%	no data
0.096%	State Street Global Advisors, Inc.	43,495	₩255.8m	0%	no data
0.025%	NH-Amundi Asset Management	11,291	₩66.4m	0%	no data
0.016%	Shinhan Asset Management Co., Ltd.	7,480	₩44.0m	0%	no data
0.014%	Korea Investment Management Co., Ltd.	6,319	₩37.1m	0%	no data
0.011%	Genexine Co. Ltd Employee Stock Ownership Association	4,978	₩29.3m	0%	no data
0.0052%	American Century Investment Management Inc	2,382	₩14.0m	0%	no data
0.0019%	Invesco Capital Management LLC	851	₩5.0m	-71.1%	no data